2-42769348-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_012205.3(HAAO):​c.630+365C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.754 in 152,164 control chromosomes in the GnomAD database, including 43,622 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.75 ( 43622 hom., cov: 33)

Consequence

HAAO
NM_012205.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.230

Publications

4 publications found
Variant links:
Genes affected
HAAO (HGNC:4796): (3-hydroxyanthranilate 3,4-dioxygenase) 3-Hydroxyanthranilate 3,4-dioxygenase is a monomeric cytosolic protein belonging to the family of intramolecular dioxygenases containing nonheme ferrous iron. It is widely distributed in peripheral organs, such as liver and kidney, and is also present in low amounts in the central nervous system. HAAO catalyzes the synthesis of quinolinic acid (QUIN) from 3-hydroxyanthranilic acid. QUIN is an excitotoxin whose toxicity is mediated by its ability to activate glutamate N-methyl-D-aspartate receptors. Increased cerebral levels of QUIN may participate in the pathogenesis of neurologic and inflammatory disorders. HAAO has been suggested to play a role in disorders associated with altered tissue levels of QUIN. [provided by RefSeq, Jul 2008]
HAAO Gene-Disease associations (from GenCC):
  • vertebral, cardiac, renal, and limb defects syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: PanelApp Australia, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • congenital vertebral-cardiac-renal anomalies syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.835 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HAAONM_012205.3 linkc.630+365C>G intron_variant Intron 7 of 9 ENST00000294973.11 NP_036337.2
HAAOXM_011532729.4 linkc.540+365C>G intron_variant Intron 6 of 8 XP_011531031.1
HAAOXM_011532730.4 linkc.528+365C>G intron_variant Intron 8 of 10 XP_011531032.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HAAOENST00000294973.11 linkc.630+365C>G intron_variant Intron 7 of 9 1 NM_012205.3 ENSP00000294973.6
HAAOENST00000402698.6 linkn.974+365C>G intron_variant Intron 6 of 8 5
HAAOENST00000404451.7 linkn.389+795C>G intron_variant Intron 5 of 5 3
HAAOENST00000406007.6 linkn.181+365C>G intron_variant Intron 1 of 3 2

Frequencies

GnomAD3 genomes
AF:
0.754
AC:
114616
AN:
152046
Hom.:
43585
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.843
Gnomad AMI
AF:
0.582
Gnomad AMR
AF:
0.808
Gnomad ASJ
AF:
0.786
Gnomad EAS
AF:
0.690
Gnomad SAS
AF:
0.850
Gnomad FIN
AF:
0.671
Gnomad MID
AF:
0.886
Gnomad NFE
AF:
0.698
Gnomad OTH
AF:
0.761
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.754
AC:
114708
AN:
152164
Hom.:
43622
Cov.:
33
AF XY:
0.754
AC XY:
56038
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.842
AC:
34987
AN:
41530
American (AMR)
AF:
0.808
AC:
12357
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.786
AC:
2726
AN:
3470
East Asian (EAS)
AF:
0.689
AC:
3566
AN:
5172
South Asian (SAS)
AF:
0.850
AC:
4101
AN:
4824
European-Finnish (FIN)
AF:
0.671
AC:
7095
AN:
10578
Middle Eastern (MID)
AF:
0.878
AC:
258
AN:
294
European-Non Finnish (NFE)
AF:
0.698
AC:
47483
AN:
67992
Other (OTH)
AF:
0.763
AC:
1608
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1450
2900
4350
5800
7250
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
850
1700
2550
3400
4250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.602
Hom.:
1581
Bravo
AF:
0.767
Asia WGS
AF:
0.782
AC:
2717
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
3.6
DANN
Benign
0.77
PhyloP100
-0.23
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4953658; hg19: chr2-42996488; API